We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

hp

Advertise with Us

Latest Issue

Expo Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events

Expo

MEDLAB Clinical Chem.Molecular DiagnosticsHematologyImmunologyMicrobiologyPathologyTechnologyIndustry Events Advertise with Us

INTEGRA BIOSCIENCES AG

DYMIND BIOTECHNOLOGY

Dymind designs, manufactures and sells a range of auto hematology analyzers and home ventilator. The company also off... read more Featured Products:

3-Part Auto Hematology Analyzer

Automatic Chemiluminescence Analyzer

3-Part Hematology Analyzer

Automatic Coagulation Analyzer

Mini 5-Part Hematology Analyzer

More products

DIASYS DIAGNOSTIC SYSTEMS

Enhancing Efficiency in Laboratory Medicine - A Focus on Quality Control Procedures.

Labmedica Webinars

Download Mobile App

Video Library

more videos

First-Of-Its-Kind Smartphone Technology Noninvasively Measures Blood Hemoglobin Levels at POC

New Blood Test Platform Simultaneously Measures Over 100 Biomarkers of Alzheimer's Disease

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Dymind Introduces New High-End Hematology Analyzer with Innovative Functions

By LabMedica International staff writers
Posted on 06 Feb 2024

Image: The new high-end DH-800 hematology analyzer showcased at Medlab Middle East 2024 (Photo courtesy of Dymind)

Image: The new high-end DH-800 hematology analyzer showcased at Medlab Middle East 2024 (Photo courtesy of Dymind)

Dymind Biotechnology (Shenzhen, China) is introducing its breakthroughs in medical solutions for hematology, coagulation, POCT, immunology, and veterinary at Medlab Middle East 2024, including its new high-end hematology analyzer DH-800 with and innovative functions.

Leveraging cutting-edge laser scattering fluorescent technology, intelligent warm bath technology, and advanced AI cube technology, DH-800 revolutionizes WBC/RBC/PLT detection. In addition to offering powerful detection for abnormal WBC/RBC/PLT, it also provides unprecedented automation for daily operation and maintenance. Featuring an enhanced automatic detection system for capillary blood, it offers various and flexible sampling modes. Other features include a 15.5-inch intuitive touchscreen, rotatable barcode scanning, bionic swirl mixing, closed puncture sampling, and 3D fluorescent analysis.

Dymind is also highlighting the CA1200 fully automated coagulation analyzer which integrates optical clotting and magnetic bead clotting methods for reliable results. The CA1200 features an adjustable touchscreen and interior lighting to maximize convenience along with an intelligent design to optimize workflow. At Medlab Middle East 2024, Dymind is also showcasing the DH20 3-part auto hematology analyzer. Compact and user-friendly, the DH20 can measure more clinical parameters using only 9ul sample volume and comes with an optional RF card and barcode function.

Related Links:
Dymind Biotechnology

Visit expo >

New

Gold Member

Veterinary Hematology Analyzer

Exigo H400

Gold Member

Serological Pipet Controller

PIPETBOY GENIUS

New

Blood Gas Panel plus Electrolytes

i-STAT EG6+ Cartridge

New

Anti-Annexin V IgG/IgM Assay

Anti-Annexin V IgG/IgM ELISA

Latest Medlab 2024 News

Channels

Clinical Chemistry

view channel

AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood

Accurately monitoring drug levels in the blood is essential for effective treatment, particularly in the management of cardiovascular diseases. Traditional techniques for monitoring blood drug levels often... Read more

Image: The LC-MS/MS assay can serve as a reference method to validate emerging biosensors for renal function monitoring (Photo courtesy of 123RF)

Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva

Timely and accurate monitoring of renal function is essential for managing patients at risk of acute kidney injury (AKI), which affects about 12% of hospitalized patients and up to 57% of ICU patients.... Read more

Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection

Nanopores are tiny openings that can detect individual molecules as they pass through, making them ideal for analyzing biomolecules like DNA and proteins. However, detecting proteins at extremely low ... Read more

Image: Rapid and non-invasive analysis of paracetamol overdose using paper arrow-mass spectrometry (Photo courtesy of Dr Simon Maher/University of Liverpool)

New Saliva Test Rapidly Identifies Paracetamol Overdose

Paracetamol is the most widely used medication worldwide, and its easy availability contributes to its frequent misuse and overdose. Overdosing on paracetamol can lead to liver toxicity, requiring hospitalization.... Read more

Molecular Diagnostics

view channel

Image: Umbilical cord blood biomarkers may improve preterm infant care (Photo courtesy of Shutterstock)

Umbilical Cord Blood Test Could Identify Preterm Infants at Risk for Medical Complications

Advancements in medical technology and neonatology have significantly improved the care of prematurely born infants. However, these infants still face heightened risks for medical complications, such as... Read more

Breakthrough Technology Represents Leap Forward in Next-Generation Sequencing

Next-generation sequencing (NGS) has revolutionized our understanding of genetics, genomics, and cell biology, offering detailed insights that are essential for decoding complex diseases such as cancer,... Read more

Image: The blood test uses lipids to identify children who are more susceptible to obesity-related problems (Photo courtesy of 123RF)

New Lipid Blood Test Identifies Children at Risk of Diabetes

Lipids have traditionally been considered as fatty acids in the body, including the different types of cholesterol or triglycerides, which are fats found in the bloodstream and are the most common in the human body.... Read more

‘Super Test’ for Prostate Cancer to Revolutionize Screening and Diagnosis

Each year, there are 55,000 new cases of prostate cancer in the UK, over 330,000 across the European Union, and more than one million men receiving treatment at any given time. Most men initially undergo... Read more

Hematology

view channel

Image: Leukocyte count represents an easily accessible, inexpensive clinical marker (Photo courtesy of 123RF)

WBC Count Could Predict Severity of COVID-19 Symptoms

The global health crisis caused by the SARS-CoV-2 virus continues to impact millions of people worldwide, with many experiencing persistent symptoms months after the initial diagnosis. Cognitive impairment... Read more

Image: The high precision platelet counting technology reduces risks that can lead to errors in cancer diagnoses (Photo courtesy of Adobe Stock)

New Platelet Counting Technology to Help Labs Prevent Diagnosis Errors

Accurate platelet count testing is a significant challenge for laboratories. Inaccurate results can lead to misdiagnosis, missed diagnoses, and delayed treatment for a variety of potentially fatal conditions,... Read more

Image: The study examined the diagnostic utility of ELISA testing for heparin-induced thrombocytopenia (Photo courtesy of 123RF)

Streamlined Approach to Testing for Heparin-Induced Thrombocytopenia Improves Diagnostic Accuracy

Heparin-induced thrombocytopenia (HIT), a serious side effect of the blood thinner heparin, is difficult to diagnose because thrombocytopenia, or low platelet count, can be caused by a variety of factors... Read more

Image: The Quantra Hemostasis System with QStat Cartridge (Photo courtesy of HemoSonics)

POC Hemostasis System Could Help Prevent Maternal Deaths

Postpartum hemorrhage (PPH), which refers to severe bleeding following childbirth, is the leading cause of maternal deaths globally. Every year, about 14 million women experience PPH, and approximately... Read more

Immunology

view channel

3D Bioprinted Gastric Cancer Model Uses Patient-Derived Tissue Fragments to Predict Drug Response

Tumor heterogeneity presents a major obstacle in the development and treatment of cancer therapies, as patients' responses to the same drug can differ, and the timing of treatment significantly influences prognosis. Consequently, technologies that predict the effectiveness of anticancer treatments are essential in minimizing... Read more

Image: The blood test for fungal infections provides faster results and has a less invasive process (Photo courtesy of 123RF)

Blood Test for Fungal Infections Could End Invasive Tissue Biopsies

For individuals with weakened immune systems, common molds found in the environment—such as in the soil, on damp walls, or on forgotten fruits—can lead to severe infections deep within the body.... Read more

Image: Example image of the high-throughput microscopy method used in the study, showing immune cells stained with different fluorescence markers (Photo courtesy of Felix Kartnig/CeMM, MedUni Vienna)

Cutting-Edge Microscopy Technology Enables Tailored Rheumatology Therapies

Rheumatoid arthritis is the most common inflammatory joint disorder, with women three times as likely to suffer from the condition as men. Treatment advances made over the past decades have led to the... Read more

New Discovery in Blood Immune Cells Paves Way for Parkinson's Disease Diagnostic Test

Parkinson’s disease is the fastest-growing neurological disorder globally and is the second most common after Alzheimer’s disease. Parkinson’s is a neurodegenerative condition, meaning it worsens progressively,... Read more

Microbiology

view channel

Rapid Sepsis Diagnostic Test Demonstrates Improved Patient Care and Cost Savings in Hospital Application

Sepsis is the leading cause of death and the most expensive condition treated in U.S. hospitals. The risk of death from sepsis increases by up to 8% for each hour that treatment is delayed, making early... Read more

Image: The rapid diagnostic to detect neonatal sepsis can provide results within hours versus days (Photo courtesy of 123RF)

Rapid Diagnostic System to Detect Neonatal Sepsis Within Hours

Neonatal sepsis is a life-threatening condition caused by bloodstream infections in newborns under 28 days old. Due to their underdeveloped immune systems, newborns are particularly vulnerable to infections.... Read more

Novel Test to Diagnose Bacterial Pneumonia Directly from Whole Blood

Pneumonia and lower-respiratory-tract infections (LRTIs) are among the top causes of illness and death globally, particularly in vulnerable populations such as the elderly, young children, and immunocompromised... Read more

Interferon-γ Release Assay Effective in Patients with COPD Complicated with Pulmonary Tuberculosis

Chronic obstructive pulmonary disease (COPD) is a common respiratory condition and a major chronic lung disease that significantly impacts public health and work capacity. Long-term respiratory infections... Read more

Pathology

view channel

Machine Learning Tool Enables AI-Assisted Diagnosis of Immunological Diseases

Traditional diagnostic methods for autoimmune diseases and other immunological conditions typically combine physical examinations, patient history, and laboratory tests to detect cellular or molecular abnormalities.... Read more

Image: Michelle Lo (right), the primary developer of CytoMAD in this project, alongside Professor Kevin Tsia (left), the research team leader (Photo courtesy of HKU)

AI-Driven Tool to Accelerate Cancer Diagnosis

In order to address the challenge of low visibility when examining cell samples under a microscope, medical professionals typically use staining and labeling techniques. However, this process is not only... Read more

Image: The OmicsFootPrint AI tool could open doors to new discoveries (Photo courtesy of Mayo Clinic)

Revolutionary AI Tool Transforms Disease Visualization

Genes serve as the body's blueprint, while proteins execute the instructions within those blueprints to maintain cell function. Occasionally, alterations in these instructions—known as mutations—can interfere... Read more

Image: The plasma cell dataset was created to assist in the accurate diagnosis (Photo courtesy of Shutterstock)

Novel Dataset of Plasma Cells to Aid Diagnosis of Multiple Myeloma

Myeloma is a rare blood cancer that originates in plasma cells, a type of immune cell responsible for producing antibodies that help fight infections. The disease begins when an abnormal plasma cell starts... Read more

Technology

view channel

Image: Deep learning-enhanced chemiluminescence vertical flow assay for high-sensitivity cardiac Troponin I testing (Photo courtesy of Ozcan Lab/UCLA)

POC Paper-Based Sensor Platform to Transform Cardiac Diagnostics

Cardiovascular diseases continue to be the leading cause of death worldwide, accounting for over 19 million fatalities annually. Early detection of myocardial infarction (MI), commonly known as a heart... Read more

Study Explores Impact of POC Testing on Future of Diagnostics

In today’s rapidly changing world, having quick and accurate access to medical information is more crucial than ever. Point-of-Care Diagnostics (PoC-D) and Point-of-Care Testing (PoC-T) are making this... Read more

Image: The new screening device has shown promise for early lung cancer detection (Photo courtesy of Biosensors, DOI: 10.3390/bios14120624)

Low-Cost, Fast Response Sensor Enables Early and Accurate Detection of Lung Cancer

Cancer biomarkers are valuable tools for early diagnosis as their concentration in body fluids, such as serum, can be measured to detect the disease at an earlier stage. Additionally, serum levels of these... Read more

Image: The nanomaterial passively captures and preserves DNA and cells of interest from menstrual blood for testing (Photo courtesy of CELLECT)

Nanotechnology For Cervical Cancer Diagnosis Could Replace Invasive Pap Smears

Cervical cancer is the fourth most common cancer in women globally, almost always caused by the human papillomavirus (HPV), which spreads through sexual contact. The Pap test (or Pap smear) is used to... Read more

Industry

view channel

Bio-Rad to Acquire Digital PCR Developer Stilla Technologies

Bio-Rad Laboratories (Hercules, CA, USA) has entered into a binding offer to purchase all equity interests in Stilla Technologies (Villejuif, France). The acquisition remains subject to consultation with... Read more

Image: ABL and affiliates will start production and commercialization of FTD’s new UltraGene products based on PCR tests (Photo courtesy of Siemens)

ABL Signs Know-How License and Transfer Agreement for Siemens’ Fast Track Diagnostics PCR Portfolio

Advanced Biological Laboratories (ABL, Luxembourg Ville, Luxembourg) has signed a licensing and transfer agreement with Siemens Healthineers (Forchheim, Germany) for the know-how and IP rights from Fast... Read more

Becton Dickinson to Spin Out Biosciences and Diagnostic Solutions Business

Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) has announced that its board of directors has unanimously authorized the management to pursue a plan to separate BD's Biosciences and Diagnostic... Read more

Image: Discovery will deploy PathAI’s AISight IMS, ArtifactDetect, and TumorDetect products globally across its biospecimens business (Photo courtesy of PathAI)

New Partnership Revolutionizes Analyses of Biological Samples

PathAI (Boston, MA, USA), a leading provider of artificial intelligence (AI)-powered technology for pathology, has entered into a strategic partnership with Discovery Life Sciences (Huntsville, AL, USA),... Read more

MEDLAB 2024

LabMedica

About Us
Advertising Info
Subscription
Client Login
Privacy Policy
Cookie Policy
Journal Info
Contact Us

Channels

Clinical Chem.
Molecular Diagnostics
Hematology
Immunology
Microbiology
Pathology
Technology
BioResearch
Industry
Events
Focus

Features

Events Product Showcase LinkXpress Whitepapers archive Video Library

Partner Sites

LabMedica Expo HospiMedica.com Globetech.net

Archive:

BioResearch
COVID-19

2024
Medica ADLM 2023
Medica AACC EUROMEDLAB 2022
MEDICA

AACC ECCMID EUROMEDLAB 2021
Medica AACC 2020
AACC COV 2019
Medica

Copyright © 2000-2025 Globetech Media. All rights reserved.

MOBILE | FULL SITE